Jane Street Group LLC Decreases Stake in MeiraGTx Holdings plc (NASDAQ:MGTX)

Jane Street Group LLC decreased its holdings in MeiraGTx Holdings plc (NASDAQ:MGTX) by 59.3% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 21,442 shares of the company’s stock after selling 31,191 shares during the quarter. Jane Street Group LLC’s holdings in MeiraGTx were worth $89,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Rhumbline Advisers increased its position in shares of MeiraGTx by 10.8% in the second quarter. Rhumbline Advisers now owns 52,996 shares of the company’s stock worth $223,000 after acquiring an additional 5,178 shares in the last quarter. American Century Companies Inc. boosted its position in MeiraGTx by 42.4% during the 2nd quarter. American Century Companies Inc. now owns 40,008 shares of the company’s stock worth $168,000 after purchasing an additional 11,907 shares during the period. Dimensional Fund Advisors LP increased its holdings in MeiraGTx by 14.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 462,950 shares of the company’s stock valued at $1,949,000 after purchasing an additional 58,854 shares in the last quarter. Hsbc Holdings PLC raised its position in MeiraGTx by 100.9% in the second quarter. Hsbc Holdings PLC now owns 23,954 shares of the company’s stock valued at $102,000 after purchasing an additional 12,029 shares during the period. Finally, Squarepoint Ops LLC acquired a new position in shares of MeiraGTx during the second quarter worth about $123,000. 67.48% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

MGTX has been the subject of a number of recent research reports. Royal Bank of Canada increased their target price on MeiraGTx from $9.00 to $11.00 and gave the company an “outperform” rating in a research note on Thursday, November 14th. Chardan Capital reaffirmed a “buy” rating and issued a $36.00 price objective on shares of MeiraGTx in a research report on Monday, November 18th.

Insider Buying and Selling

In related news, CEO Alexandria Forbes sold 35,839 shares of MeiraGTx stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $6.47, for a total value of $231,878.33. Following the completion of the sale, the chief executive officer now owns 1,395,102 shares in the company, valued at approximately $9,026,309.94. The trade was a 2.50 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 8.40% of the company’s stock.

MeiraGTx Stock Performance

Shares of MGTX stock opened at $5.77 on Wednesday. The company’s fifty day moving average price is $6.29 and its two-hundred day moving average price is $5.16. The company has a debt-to-equity ratio of 0.86, a current ratio of 2.34 and a quick ratio of 2.34. The firm has a market capitalization of $450.94 million, a P/E ratio of -4.77 and a beta of 1.26. MeiraGTx Holdings plc has a 12 month low of $3.85 and a 12 month high of $7.37.

MeiraGTx Profile

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.